{Reference Type}: Journal Article
{Title}: Recent Advances in Positron Emission Tomography Radiotracers to Image Cardiac Amyloidosis.
{Author}: Romero Pabón AJ;Clerc OF;Vijayakumar S;Cuddy SAM;Dorbala S;
{Journal}: Curr Cardiol Rep
{Volume}: 0
{Issue}: 0
{Year}: 2024 Aug 13
{Factor}: 3.955
{DOI}: 10.1007/s11886-024-02114-6
{Abstract}: Cardiac amyloidosis includes a group of protein-misfolding diseases characterized by fibril accumulation within the extracellular space of the myocardium and cardiac dysfunction. Cardiac amyloidosis has high mortality. Emerging radionuclide techniques have helped us to better understand disease pathogenesis, prognostication, and treatment response in cardiac amyloidosis. PURPOSE OF REVIEW: To review recent advances in molecular imaging of cardiac amyloidosis using amyloid PET radiotracers. RECENT FINDINGS: Multiple single center studies have shown that amyloid PET radiotracers allow definitive diagnosis and quantification of cardiac amyloid burden. These amyloid targeting tracers may provide means to improve early disease detection, risk stratification and treatment monitoring. Amyloid PET imaging may inform definitive imaging-based diagnosis for therapeutic decisions, risk stratification, and treatment monitoring. More research in unselected cohorts of patients with suspected cardiac amyloidosis is needed to optimize the clinical implementation of amyloid PET imaging.